Progress and controversy on diagnosis and treatment of gastric stump cancer.
- Author:
Zhidong GAO
1
;
Yongbai LI
;
Kewei JIANG
;
Yingjiang YE
;
Shan WANG
2
Author Information
1. Department of Gastrointestinal Surgery, Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing 100044, China. gaozhidong@pkuph.edu.cn.
2. Department of Gastrointestinal Surgery, Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing 100044, China. shanwang@pkuph.edu.cn.
- Publication Type:Journal Article
- MeSH:
Gastrectomy;
Gastric Stump;
pathology;
surgery;
Helicobacter Infections;
complications;
Humans;
Lymph Node Excision;
Male;
Stomach Neoplasms;
surgery
- From:
Chinese Journal of Gastrointestinal Surgery
2018;21(5):588-592
- CountryChina
- Language:Chinese
-
Abstract:
Gastric stump cancer (GSC) is a carcinoma arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men. The risk of morbidity has an obvious time dependence. GSC incidence is likely to rise with lengthening of the initial operation interval. The GSC time interval after malignant disease is significantly shorter than that of benign disease. GSC etiologies mainly include duodenogastric reflux and denervation of the gastric mucosa resulting in the change of the gastric environment after gastrectomy and the Helicobacter pylori infection. Due to atypical clinical symptoms, GSC is always identified at an advanced stage and the long-term survival rate is low. An optimal endoscopic surveillance system is essential to improve early detection rates. Treatments in GSC and primary gastric cancer are the same and include resection of the lesion and radical lymph node dissection. R0 resection is an important prognostic factor. Here we review previous reports with respect to epidemiological characteristics, etiology, clinical symptoms, treatment, and prognosis of GSC.
